Surrozen (SRZN) Proxy filing summary

Executive summary

• Annual meeting scheduled for May 13, 2026, to be held virtually for shareholder participation.

• Shareholders are encouraged to review proxy materials and vote by May 12, 2026.

Voting matters and shareholder proposals

• Election of two Class II directors to serve until the 2029 annual meeting.

• Ratification of Ernst & Young LLP as independent auditor for the year ending December 31, 2026.

• Advisory approval of executive compensation for named executive officers.

• Advisory vote on the preferred frequency of future say-on-pay votes.

Board of directors and corporate governance

• Nominees for Class II director positions are Mace Rothenberg, M.D., and David J. Woodhouse, Ph.D.